Endometrial Carcinoma

Who we are

  • January 9, 2024
    NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
  • April 5, 2022
    Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)